Intriguingly, through the integrative bioinformatics and experimental analysis, the expression of CDC42EP3 was found to be down-regulated in ovarian cancer tissues and cells, and its low level was associated with poor prognosis. This evidence concerns the gene CDC42EP3 and ovarian cancer.